Literature DB >> 23777450

N-linked glycan structures of the human Fcγ receptors produced in NS0 cells.

Eoin F J Cosgrave1, Weston B Struwe, Jerrard M Hayes, David J Harvey, Mark R Wormald, Pauline M Rudd.   

Abstract

Immune recognition of nonself is coordinated through complex mechanisms involving both innate and adaptive responses. Circulating antibodies communicate with effector cells of the innate immune system through surface receptors known as Fcγ receptors (FcγRs). The FcγRs are single-pass transmembrane glycoproteins responsible for regulating innate effector responses toward antigenic material. Although immunoglobulin G (IgG) antibodies bind to a range of receptors, including complement receptors and C-type lectins, we have focused on the Fcγ receptors. A total of five functional FcγRs are broadly classified into three families (FcγRI, FcγRII, and FcγRIII) and together aid in controlling both inflammatory and anti-inflammatory responses of the innate immune system. Due to the continued success of monoclonal antibodies in treating cancer and autoimmune disorders, research is typically directed toward improving the interaction of antibodies with the FcγRs through manipulation of IgG properties such as N-linked glycosylation. Biochemical studies using recombinant forms of the FcγRs are often used to quantitate changes in binding affinity, a key indicator of a likely biological outcome. However, analysis of the FcγRs themselves is imperative as recombinant FcγRs differ greatly from those observed in humans. In particular, the N-linked glycan composition is significantly important due to its function in the IgG-FcγR interaction. Here, we present data for the N-linked glycans present on FcγRs produced in NS0 cells, namely, FcγRIa, FcγRIIa, FcγRIIB, FcγRIIIa, and FcγRIIIb. Importantly, these FcγRs demonstrate typical murine glycosylation in the form of α-galactose epitopes, N-glycolylneuraminic acid, and other key glycan properties that are generally expressed in murine cell lines and therefore are not typically observed in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23777450     DOI: 10.1021/pr400344h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  12 in total

Review 1.  Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

Authors:  Christopher T Saeui; Esteban Urias; Lingshu Liu; Mohit P Mathew; Kevin J Yarema
Journal:  Glycoconj J       Date:  2015-05-01       Impact factor: 2.916

2.  Impact of N-glycosylation on Fcγ receptor / IgG interactions: unravelling differences with an enhanced surface plasmon resonance biosensor assay based on coiled-coil interactions.

Authors:  Florian Cambay; Olivier Henry; Yves Durocher; Gregory De Crescenzo
Journal:  MAbs       Date:  2019-03-05       Impact factor: 5.857

3.  Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.

Authors:  Jerrard M Hayes; Asa Frostell; Robert Karlsson; Steffen Müller; Silvia Míllan Martín; Martin Pauers; Franziska Reuss; Eoin F Cosgrave; Cecilia Anneren; Gavin P Davey; Pauline M Rudd
Journal:  Mol Cell Proteomics       Date:  2017-06-02       Impact factor: 5.911

4.  Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function.

Authors:  Kashyap R Patel; Jacob T Roberts; Ganesh P Subedi; Adam W Barb
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

5.  Post-HDX Deglycosylation of Fc Gamma Receptor IIIa Glycoprotein Enables HDX Characterization of Its Binding Interface with IgG.

Authors:  Nicole D Wagner; Yining Huang; Tun Liu; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2021-02-24       Impact factor: 3.262

Review 6.  Fc gamma receptors: glycobiology and therapeutic prospects.

Authors:  Jerrard M Hayes; Mark R Wormald; Pauline M Rudd; Gavin P Davey
Journal:  J Inflamm Res       Date:  2016-11-16

7.  Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum.

Authors:  Hirokazu Yagi; Daisuke Takakura; Lubka T Roumenina; Wolf Herman Fridman; Catherine Sautès-Fridman; Nana Kawasaki; Koichi Kato
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

Review 8.  Multiple Variables at the Leukocyte Cell Surface Impact Fc γ Receptor-Dependent Mechanisms.

Authors:  Kashyap R Patel; Jacob T Roberts; Adam W Barb
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

9.  Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.

Authors:  Ryuta Wada; Makoto Matsui; Nana Kawasaki
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

10.  Characterization of Endogenous Human FcγRIII by Mass Spectrometry Reveals Site, Allele and Sequence Specific Glycosylation.

Authors:  Nathaniel Washburn; Robin Meccariello; Jay Duffner; Kristen Getchell; Kimberly Holte; Thomas Prod'homme; Karunya Srinivasan; Robert Prenovitz; Jonathan Lansing; Ishan Capila; Ganesh Kaundinya; Anthony M Manning; Carlos J Bosques
Journal:  Mol Cell Proteomics       Date:  2018-12-17       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.